BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33890424)

  • 1. Effect of Recombinant Human Perlecan Domain V Tethering Method on Protein Orientation and Blood Contacting Activity on Polyvinyl Chloride.
    Chandrasekar K; Farrugia BL; Johnson L; Marks D; Irving D; Elgundi Z; Lau K; Kim HN; Rnjak-Kovacina J; Bilek MM; Whitelock JM; Lord MS
    Adv Healthc Mater; 2021 Jul; 10(14):e2100388. PubMed ID: 33890424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic silk biomaterials: Perlecan-functionalized silk fibroin for use in blood-contacting devices.
    Lau K; Waterhouse A; Akhavan B; Gao L; Kim HN; Tang F; Whitelock JM; Bilek MM; Lord MS; Rnjak-Kovacina J
    Acta Biomater; 2021 Sep; 132():162-175. PubMed ID: 33588126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant perlecan domain V covalently immobilized on silk biomaterials via plasma immersion ion implantation supports the formation of functional endothelium.
    Lau K; Fu L; Zhang A; Akhavan B; Whitelock J; Bilek MM; Lord MS; Rnjak-Kovacina J
    J Biomed Mater Res A; 2023 Jun; 111(6):825-839. PubMed ID: 36897070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications.
    Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS
    Colloids Surf B Biointerfaces; 2016 Dec; 148():130-138. PubMed ID: 27591944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.
    Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS
    Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Glycoprotein VI-Dependent Platelet Activation and Thrombus Formation by Heparan Sulfate Proteoglycan Perlecan.
    Provenzale I; De Simone I; Gibbins JM; Heemskerk JWM; van der Meijden PEJ; Jones CI
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
    Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
    Hayashi K; Madri JA; Yurchenco PD
    J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Biofunctionalization of Silk Biomaterials Using Dityrosine Cross-Linking.
    Karimi F; Lau K; Kim HN; Och Z; Lim KS; Whitelock J; Lord M; Rnjak-Kovacina J
    ACS Appl Mater Interfaces; 2022 Jul; 14(28):31551-31566. PubMed ID: 35793155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning Recombinant Perlecan Domain V to Regulate Angiogenic Growth Factors and Enhance Endothelialization of Electrospun Silk Vascular Grafts.
    Jiang S; Yang N; Tan RP; Moh ESX; Fu L; Packer NH; Whitelock JM; Wise SG; Rnjak-Kovacina J; Lord MS
    Adv Healthc Mater; 2024 May; ():e2400855. PubMed ID: 38780418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor.
    Bengtsson E; Mörgelin M; Sasaki T; Timpl R; Heinegård D; Aspberg A
    J Biol Chem; 2002 Apr; 277(17):15061-8. PubMed ID: 11847210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
    Doege K; Chen X; Cornuet PK; Hassell J
    Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.
    Göhring W; Sasaki T; Heldin CH; Timpl R
    Eur J Biochem; 1998 Jul; 255(1):60-6. PubMed ID: 9692901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
    Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
    J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
    Murdoch AD; Dodge GR; Cohen I; Tuan RS; Iozzo RV
    J Biol Chem; 1992 Apr; 267(12):8544-57. PubMed ID: 1569102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
    Friedrich MV; Schneider M; Timpl R; Baumgartner S
    Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells.
    Yamamoto C; Wakata T; Fujiwara Y; Kaji T
    Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
    Dodge GR; Boesler EW; Jimenez SA
    Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
    Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
    Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.